|
Market Closed -
Nasdaq
16:00:00 2026-09-09 EDT
|
5-day change | 1st Jan Change | ||
| 5.150 USD | -1.15% |
|
-4.28% | -20.28% |
| 08-12 | Aquestive Therapeutics, Inc., Q2 2026 Earnings Call, Aug 12, 2026 | |
| 08-11 | Aquestive Therapeutics Q2 Loss Widens, Revenue Rises | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 654M | - | ||||
| 1,002B | |||||
| 649B | - | - | - | ||
| 440B | |||||
| 346B | |||||
| 263B |
Select your edition
All financial news and data tailored to specific country editions
